NIH-funded research R01 grant

How loss of the AMPK energy sensor may help melanoma spread to the brain

Official title: Role of AMPK in melanoma brain metastasis

Funded at Cedars-Sinai Medical Center · NIH-11253302 · Data updated 2026-11-12

This project checks whether losing the AMPKα2 protein helps melanomas—especially NF1-mutant tumors—grow and spread to the brain.

More Metastasis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2027
Funding year2026
Award (this year)$604,174
NIH project number5R01CA276448-05
Project IDNIH-11253302 on NIH RePORTER

Who could benefit from this research

Could help

Patients with cutaneous melanoma—particularly those whose tumors have NF1 mutations or who have brain metastases—would be most relevant to this work.

Less likely to help

People without melanoma or with melanoma that lacks relevant AMPK/NF1 changes are unlikely to get direct benefit from this specific research.

What this research studies

The team will compare tumor tissue from patients' brain metastases and matching extracranial metastases to look for loss of AMPKα2. In the lab they will use cell-based assays and mouse models, including mice engineered to lack AMPKα2 and syngeneic models that include immune effects, to see how AMPKα2 loss changes tumor growth and spread. They will also test human melanoma cells with NF1 mutations in xenografts to observe brain-colonizing behavior. Results from mice and cells will be linked back to patient samples to determine clinical relevance.

Why it matters

Potential benefit: If successful, this work could point to a new marker or therapeutic approach to prevent or treat melanoma brain metastases.

How similar studies have gone: Early lab and animal data from the investigators suggest AMPKα2 loss promotes melanoma growth and brain spread, but translating AMPK-targeted approaches to patients is still experimental.

Where this research is happening

  • Cedars-Sinai Medical Center
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Zheng, Bin — Cedars-Sinai Medical Center
  • Study coordinator: Zheng, Bin

Related research

Other NIH-funded projects on the same topics.

  • Investigating how AMPK affects melanoma spreading to the brain

    This study is looking at how a protein called AMPK affects the spread of melanoma to the brain, using samples from people and mice, to help find better treatments for patients whose melanoma has advanced to that stage.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11008933

  • Understanding how melanoma spreads to the brain

    This study is looking into how a specific gene called CNDP1 helps melanoma spread to the brain, with the hope of finding new ways to treat patients who are facing this serious challenge.

    NIH research New York University School of Medicine · New York, United States · NIH-11002724

  • Nanoparticles that boost MRI to find tiny brain metastases

    This uses tiny magnetic nanoparticles and new MRI image processing to help doctors find very small brain metastases earlier in people with cancer.

    NIH research University of California at Davis · Davis, United States · NIH-11467320

  • Prolactin signaling and brain metastasis in HER2-positive breast cancer

    Researchers are studying how prolactin signals help HER2-positive breast cancer cells grow in the brain, with the goal of finding new ideas to prevent brain metastases.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11434654

  • ATM kinase as a target to help NSCLC with brain metastases respond to treatment

    A study from Yale University tests whether blocking ATM kinase can delay or overcome treatment resistance in people with advanced non-small cell lung cancer that has spread to the brain and other organs.

    NIH research Yale University · New Haven, United States · NIH-11417454

  • How an immune signal in brain support cells helps breast cancer spread to the brain

    This project looks at whether a specific immune signal in brain support cells (astrocytes) helps breast cancer cells grow in the brain, aiming to help people with breast cancer that has spread to the brain.

    NIH research Research Inst of Fox Chase Can Ctr · Philadelphia, United States · NIH-11415817

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.